经颅超声诊断帕金森病的研究进展
Advances in the Diagnosis of Parkinson’s Disease by Transcranial Ultrasound
DOI: 10.12677/ACM.2023.1351042, PDF,   
作者: 何思敏, 张群霞*:重庆医科大学附属第二医院超声科超声分子影像重庆市重点实验室,重庆
关键词: 帕金森病超声检查经颅Parkinson’s Disease Ultrasonography Transcranial
摘要: 帕金森病是临床常见的慢性神经退行性病,早期疾病症状不典型,临床体征和症状易与其他神经退行性病等有重叠。经颅超声主要观察中脑中缝和基底节为帕金森临床诊断提供参考信息。并且黑质异常高回声是经颅超声诊断帕金森病的重要征象,但黑质高回声发生机制尚不清楚,其具体诊断标准与在临床鉴别诊断中的作用仍需更多研究明确。本文就经颅超声在帕金森病诊断中的研究进展进行综述。
Abstract: Parkinson’s disease is a common chronic neurodegenerative disease. Its early symptoms are atypi-cal, and its clinical signs and symptoms are prone to overlap with other neurodegenerative diseases. Transcranial ultrasound mainly scans the midbrain raphe and basal ganglia to provide reference information for the clinical diagnosis of Parkinson’s. Moreover, abnormal hyper echogenicity in the substantia nigra is an important sign of transcranial ultrasound in the diagnosis of Parkinson’s dis-ease. However, the mechanism of hyper echogenicity in the substantia nigra is still unclear, and its specific diagnostic criteria and role in clinical differential diagnosis still need more research. This article reviews the research progress of transcranial ultrasound in the diagnosis of Parkinson’s dis-ease.
文章引用:何思敏, 张群霞. 经颅超声诊断帕金森病的研究进展[J]. 临床医学进展, 2023, 13(5): 7466-7470. https://doi.org/10.12677/ACM.2023.1351042

参考文献

[1] Jokar, M., et al. (2023) Diagnosing Parkinson’s Disease by Combining Neuromelanin and Iron Imaging Features Using an Automated Midbrain Template Approach. NeuroImage, 266, Article ID: 119814. [Google Scholar] [CrossRef] [PubMed]
[2] Becker, G., Seufert, J., Bogdahn, U., Reichmann, H. and Reiners, K. (1995) Degeneration of Substantia Nigra in Chronic Parkinson’s Disease Visualized by Transcranial Col-or-Coded Real-Time Sonography. Neurology, 45, 182-184. [Google Scholar] [CrossRef
[3] Berardelli, A., et al. (2013) EFNS/MDS-ES Recommendations for the Diagnosis of Parkinson’s Disease. European Journal of Neurology, 20, 16-34. [Google Scholar] [CrossRef] [PubMed]
[4] Li, J., Jin, M., Wang, L., Qin, B. and Wang, K. (2017) MDS Clinical Di-agnostic Criteria for Parkinson’s Disease in China. Journal of Neurology, 264, 476-481. [Google Scholar] [CrossRef] [PubMed]
[5] Zhang, S., et al. (2020) Substantia Nigra Hyperechogenicity Re-flects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease. Frontiers in Cellular Neuroscience, 14, Article 216. [Google Scholar] [CrossRef] [PubMed]
[6] Yuan, J., et al. (2022) Controlled Activation of TRPV1 Channels on Microglia to Boost Their Autophagy for Clearance of Alpha-Synuclein and Enhance Therapy of Parkinson’s Disease. Advanced Materials, 34, e2108435. [Google Scholar] [CrossRef] [PubMed]
[7] Li, K., et al. (2020) Substantia Nigra Echogenicity Is Associated with Serum Ferritin, Gender and Iron-Related Genes in Parkinson’s Disease. Scientific Reports, 10, Article No. 8660. [Google Scholar] [CrossRef] [PubMed]
[8] Ahmadi, S.-A., et al. (2020) Analyzing the CO-Localization of Substantia Nigra Hyper-Echogenicities and Iron Accumulation in Parkinson’s Disease: A Multi-Modal Atlas Study with Transcranial Ultrasound and MRI. NeuroImage: Clinical, 26, Article ID: 102185. [Google Scholar] [CrossRef] [PubMed]
[9] Lin, Z.-H., et al. (2022) Quercetin Protects against MPP+/MPTP-Induced Dopaminergic Neuron Death in Parkinson’s Disease by Inhibiting Ferroptosis. Oxidative Medi-cine and Cellular Longevity, 2022, Article ID: 7769355. [Google Scholar] [CrossRef] [PubMed]
[10] Yilmaz, R. and Berg, D. (2018) Transcranial B-Mode Sonography in Movement Disorders. International Review of Neurobiology, 143, 179-212. [Google Scholar] [CrossRef] [PubMed]
[11] Becker, T., et al. (1997) Parkinson’s Disease and Depression: Evi-dence for an Alteration of the Basal Limbic System Detected by Transcranial Sonography. Journal of Neurology, Neuro-surgery & Psychiatry, 63, 590-596. [Google Scholar] [CrossRef] [PubMed]
[12] Fischer, N.M., et al. (2021) Brainstem Pathologies Correlate with De-pression and Psychosis in Parkinson’s Disease. The American Journal of Geriatric Psychiatry, 29, 958-968. [Google Scholar] [CrossRef] [PubMed]
[13] Bei, H.-Z., et al. (2020) Echogenicity Changes in Brainstem Raphe Detected by Transcranial Parenchymal Sonography and Clinical Characteristics in Parkinson’s Disease. Frontiers in Neurology, 11, Article 821. [Google Scholar] [CrossRef] [PubMed]
[14] Liu, X.J., et al. (2018) Echogenic Alteration in the Raphe Nuclei Measured by Transcranial Sonography in Patients with Parkinson Disease and Depression. Medicine, 97, e13524. [Google Scholar] [CrossRef
[15] Tao, A., et al. (2020) Essential Tremor vs Idiopathic Parkin-son Disease: Utility of Transcranial Sonography. Medicine, 99, e20028. [Google Scholar] [CrossRef
[16] Wang, L.-S., Yu, T.-F., Chai, B. and He, W. (2021) Tran-scranial Sonography in Differential Diagnosis of Parkinson Disease and Other Movement Disorders. Chinese Medical Journal, 134, 1726-1731. [Google Scholar] [CrossRef
[17] Behnke, S., et al. (2019) Third Ventricular Width Assessed by Transcranial Ultrasound Correlates with Cognitive Performance in Parkinson’s Disease. Parkinsonism & Related Disorders, 66, 68-73. [Google Scholar] [CrossRef] [PubMed]
[18] Walter, U., et al. (2007) Transcranial Brain Sonography Findings in Discriminating between Parkinsonism and Idiopathic Parkinson Disease. Archives of Neurology, 64, 1635-1640. [Google Scholar] [CrossRef] [PubMed]
[19] Cheng, L., et al. (2020) Discriminative Pattern of Reduced Cerebral Blood Flow in Parkinson’s Disease and Parkinsonism-Plus Syndrome: An ASL-MRI Study. BMC Medical Imaging, 20, Article No. 78. [Google Scholar] [CrossRef] [PubMed]
[20] Skoloudik, D., et al. (2020) Digitized Image Analysis of Insula Echogenicity Detected by TCS-MR Fusion Imaging in Wilson’s and Early-Onset Parkinson’s Diseases. Ultrasound in Medicine and Biology, 46, 842-848. [Google Scholar] [CrossRef] [PubMed]
[21] Skowronska, M., Litwin, T., Kurkowska-Jastrzębska, I. and Członkowska, A. (2020) Transcranial Sonography Changes in Heterozygotic Carriers of the ATP7B Gene. Neuro-logical Sciences, 41, 2605-2612. [Google Scholar] [CrossRef] [PubMed]
[22] Godau, J., et al. (2008) Sonographic Abnormalities of Brainstem Structures in Restless Legs Syndrome. Sleep Medicine, 9, 782-789. [Google Scholar] [CrossRef] [PubMed]
[23] Zareba, M., Furman, W. and Binder, M. (2022) Influence of Age and Cognitive Performance on Resting-State Functional Connectivity of Dopaminergic and Noradrenergic Centers. Brain Research, 1796, Article ID: 148082. [Google Scholar] [CrossRef] [PubMed]
[24] Eisenberg, D.P., et al. (2022) Comparison of Transcranial So-nography and [18F]-Fluorodopa PET Imaging in GBA1 Mutation Carriers. Movement Disorders, 37, 629-634. [Google Scholar] [CrossRef] [PubMed]
[25] Ghanouni, P., et al. (2015) Transcranial MRI-Guided Focused Ultrasound: A Review of the Technologic and Neurologic Applications. American Journal of Roentgenology, 205, 150-159. [Google Scholar] [CrossRef